Enterococcus faecalis Colonization Does Not Require Treatment
Colonization with Enterococcus faecalis should not be treated with antibiotics. The critical distinction between colonization and true infection must be made before any antimicrobial therapy is initiated 1.
Key Principle: Colonization vs. Infection
The guidelines explicitly emphasize that "it is important to differentiate colonization from true infection prior to empiric prescription of anti-VRE antimicrobial agents" 1. This principle applies equally to vancomycin-susceptible E. faecalis.
When NOT to Treat (Colonization):
- Positive cultures from surveillance specimens (rectal swabs, stool cultures) without clinical infection 2
- Asymptomatic bacteriuria in non-pregnant patients without urinary symptoms
- Wound colonization without signs of active infection
- Respiratory colonization without pneumonia
When TO Treat (True Infection):
Treatment is indicated only when E. faecalis causes documented infection with clinical signs and symptoms:
For Urinary Tract Infections:
- Ampicillin remains the drug of choice for enterococcal infections 1
- High-dose ampicillin (18-30 g IV daily in divided doses) or amoxicillin 500 mg IV/PO every 8 hours for uncomplicated UTI 1
- Alternative: Fosfomycin 3 g PO single dose for uncomplicated UTI 1
- Alternative: Nitrofurantoin 100 mg PO every 6 hours 1
For Bloodstream Infections:
- Linezolid 600 mg IV or PO every 12 hours (strong recommendation) 1
- High-dose daptomycin 8-12 mg/kg IV daily, potentially combined with β-lactams 1
For Intra-abdominal Infections:
- Tigecycline 100 mg IV loading dose, then 50 mg IV every 12 hours 1
- Ampicillin 2 g every 6 hours in combination regimens 3, 4
For Endocarditis:
- Ampicillin 200 mg/kg/day IV in 4-6 doses plus gentamicin 3 mg/kg/day for 2-6 weeks 5
- Alternative: Ampicillin plus ceftriaxone 4 g/day for 6 weeks 5, 6
Critical Pitfalls to Avoid
Do not treat positive surveillance cultures: Screening cultures from stool or rectal swabs identify colonization, not infection 2
Avoid unnecessary broad-spectrum antibiotics: Inappropriate antimicrobial use drives resistance emergence 1
Do not use ineffective agents: Metronidazole, clindamycin, and cephalosporins (except in specific combinations) have poor activity against enterococci 3, 7
Recognize high-risk situations requiring anti-enterococcal coverage (these are infections, not colonization):
- Healthcare-associated intra-abdominal infections
- Post-operative infections
- Immunocompromised patients
- Patients with valvular heart disease or prosthetic materials 3
Infection Control for Colonized Patients
For patients colonized with E. faecalis (particularly vancomycin-resistant strains), focus on infection prevention rather than antimicrobial treatment:
- Contact precautions for VRE-colonized patients
- Hand hygiene compliance
- Environmental cleaning
- Removal of unnecessary catheters and devices 1, 2
The evidence consistently demonstrates that treating colonization does not improve outcomes and contributes to antimicrobial resistance. Treatment should be reserved exclusively for documented infections with clinical manifestations requiring therapy.